Latest Articles

Article Type

You have access
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
SOICHI TAKEDA, TADASHI NAMISAKI, YUKI TSUJI, YUKI FUJIMOTO, KOJI MURATA, MASAHIDE ENOMOTO, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI

Anticancer Research November 2022, 42 (11) 5465-5473; DOI: https://doi.org/10.21873/anticanres.16051
You have access
Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
HA YOUNG WOO, SEOUNG WAN CHAE, SUNG-IM DO and KIYONG NA

Anticancer Research November 2022, 42 (11) 5601-5608; DOI: https://doi.org/10.21873/anticanres.16068
Open Access
Development of Novel Small Antitumor Compounds Inhibiting PD-1/PD-L1 Binding
YASUTO AKIYAMA, TADASHI ASHIZAWA, AKIRA IIZUKA, TAKAYUKI ANDO, YOSHINOBU ISHIKAWA, RYOTA KONDOU, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TAKASHI SUGINO and KEN YAMAGUCHI

Anticancer Research November 2022, 42 (11) 5233-5247; DOI: https://doi.org/10.21873/anticanres.16030
You have access
Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients
ANDREA PANUNZIO, STEFANO TAPPERO, CRISTINA CANO GARCIA, MATTIA PICCINELLI, FRANCESCO BARLETTA, REHA-BARIS INCESU, ZHE TIAN, ALESSANDRO TAFURI, DERYA TILKI, ALBERTO BRIGANTI, OTTAVIO DE COBELLI, FELIX K.H. CHUN, CARLO TERRONE, FRED SAAD, SHAHROKH F. SHARIAT, ISABELLE BOURDEAU, MARIA ANGELA CERRUTO, ALESSANDRO ANTONELLI and PIERRE I. KARAKIEWICZ

Anticancer Research November 2022, 42 (11) 5579-5585; DOI: https://doi.org/10.21873/anticanres.16065
You have access
Evaluating Neoadjuvant Chemotherapy for Lower Esophageal Squamous Cell Carcinoma by Measuring Esophageal Wall Thickness
HIROMICHI SATO, KAZUHIRO NISHIKAWA, TAKUYA HAMAKAWA, CHIKAKO KUSUNOKI, MASAKAZU MIYAKE, ATSUSHI MIYAMOTO, TAKESHI KATO, MASAYUKI MANO, KOJI TAKAMI and MOTOHIRO HIRAO

Anticancer Research November 2022, 42 (11) 5655-5662; DOI: https://doi.org/10.21873/anticanres.16074
You have access
Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines
MASAKO ISHIGURO, TOMOKO FUKUSHIGE, HIROSHI IWASAKI and MAKOTO HAMASAKI

Anticancer Research November 2022, 42 (11) 5315-5322; DOI: https://doi.org/10.21873/anticanres.16038
You have access
Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer In Silico Analysis
PAOLA G. GONÇALVES, RUI M. REIS and LUCAS T. BIDINOTTO

Anticancer Research November 2022, 42 (11) 5291-5304; DOI: https://doi.org/10.21873/anticanres.16036
You have access
Pan-Aurora Kinase Inhibitor Danusertib Induces Apoptosis of Epstein–Barr Virus-transformed B-Cells Through Caspase and Endoplasmic Reticulum Stress Signaling
JIN SOO KIM and DAE YOUNG HUR

Anticancer Research November 2022, 42 (11) 5265-5274; DOI: https://doi.org/10.21873/anticanres.16033
You have access
The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in Gastric Cancer With Gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach
MASARU KOMATSU, TAKAHIRO KINOSHITA, EIGO AKIMOTO, MITSUMASA YOSHIDA, DAIKI TERAJIMA, HIROMI NAGATA, TAKUMI HABU, TAKAFUMI OKAYAMA, YUYA TAKABE, JUNICHIRO HARADA, MASAYUKI YAMAGUCHI and MASAHIRO YURA

Anticancer Research November 2022, 42 (11) 5571-5578; DOI: https://doi.org/10.21873/anticanres.16064
Open Access
A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy
DIRK RADES, CANSU DELIKANLI, OLIVER BLANCK, STEVEN E. SCHILD and STEFAN JANSSEN

Anticancer Research November 2022, 42 (11) 5629-5634; DOI: https://doi.org/10.21873/anticanres.16071

Main menu

User menu

Search

Latest Articles

Pages